Search research articles
Contact Us
Filters
Showing results (241-250 of 313) with videos related to
Page
of 32
Sort By:
The Journal of Infectious Diseases
|
October 9, 1999
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR
R Lagos, A Fasano, S S Wasserman, et al.
Revista Medica De Chile
|
August 1, 1993
[Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults]
R Lagos, A Avendaño, I Horwitz, et al.
JAMA
|
August 12, 2004
Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial
Karen L Kotloff, Mary Corretti, Kathleen Palmer, et al.
The American Journal of Emergency Medicine
|
February 28, 2016
Association of atrial fibrillation risk alleles and response to acute rate control therapy
Tyler W Barrett, Wesley H Self, Dawood Darbar, et al.
Pediatrics
|
February 2, 1999
Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization
G A Losonsky, S S Wasserman, I Stephens, et al.
Bulletin of the World Health Organization
|
June 6, 1998
A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali
R T Perry, C V Plowe, B Koumaré, et al.
BMJ Open Sport & Exercise Medicine
|
April 10, 2018
Evaluation of spine MRIs in athletes participating in the Rio de Janeiro 2016 Summer Olympic Games
Michael S Wasserman, Ali Guermazi, Mohamed Jarraya, et al.
Molecular Immunology
|
March 1, 1995
Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains
K M Keating, D B Segal, S J Craig, et al.
The Journal of Infectious Diseases
|
December 1, 1994
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans
R Edelman, C O Tacket, S S Wasserman, et al.
Infection and Immunity
|
September 1, 1993
Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels
E Gotuzzo, B Butron, C Seas, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 313) with videos related to
Sort By:
Page
of 32
The Journal of Infectious Diseases
|
October 9, 1999
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR
R Lagos, A Fasano, S S Wasserman, et al.
Revista Medica De Chile
|
August 1, 1993
[Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults]
R Lagos, A Avendaño, I Horwitz, et al.
JAMA
|
August 12, 2004
Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial
Karen L Kotloff, Mary Corretti, Kathleen Palmer, et al.
The American Journal of Emergency Medicine
|
February 28, 2016
Association of atrial fibrillation risk alleles and response to acute rate control therapy
Tyler W Barrett, Wesley H Self, Dawood Darbar, et al.
Pediatrics
|
February 2, 1999
Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization
G A Losonsky, S S Wasserman, I Stephens, et al.
Bulletin of the World Health Organization
|
June 6, 1998
A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali
R T Perry, C V Plowe, B Koumaré, et al.
BMJ Open Sport & Exercise Medicine
|
April 10, 2018
Evaluation of spine MRIs in athletes participating in the Rio de Janeiro 2016 Summer Olympic Games
Michael S Wasserman, Ali Guermazi, Mohamed Jarraya, et al.
Molecular Immunology
|
March 1, 1995
Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains
K M Keating, D B Segal, S J Craig, et al.
The Journal of Infectious Diseases
|
December 1, 1994
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans
R Edelman, C O Tacket, S S Wasserman, et al.
Infection and Immunity
|
September 1, 1993
Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels
E Gotuzzo, B Butron, C Seas, et al.
Page
of 32